Envoy Medical (COCH) Stock Price, News & Analysis

Company Overview

Envoy Medical (NASDAQ:COCH) is a medical device company focused on non-invasive neuromodulation therapies for dysphagia, a swallowing disorder that affects patients following neurological events or due to degenerative conditions. The company’s lead technology delivers targeted electrical stimulation designed to strengthen the muscles and neural pathways involved in the swallowing process.

Envoy Medical’s flagship therapy has received regulatory clearance from the U.S. Food and Drug Administration and is being introduced through rehabilitation centers, speech-language pathology clinics and acute care hospitals. The company works closely with healthcare providers to integrate its device into patient care pathways, supporting therapy both in clinical environments and at home.

Headquartered in the Minneapolis–Saint Paul metropolitan area, Envoy Medical currently serves the U.S. market and is evaluating opportunities for expansion into select international regions. Its leadership team combines expertise in medical device development, rehabilitation sciences and commercial operations, backed by private financing aimed at advancing innovative therapies for neurological and musculoskeletal disorders.

Key Stats

• Today's Range: $0.67 to $0.71
• 50-Day Range: $0.62 to $0.80
• 52-Week Range: $0.36 to $1.89
• Volume: 30,170 shs
• Average Volume: 332,649 shs
• Market Capitalization: $52.34 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.25
• Consensus Rating: Hold

Envoy Medical Stock Analysis - MarketRank™

Envoy Medical scored higher than 48% of companies evaluated by MarketBeat, and ranked 549th out of 902 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Envoy Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and 1 sell rating.

Upside Potential

Envoy Medical has a consensus price target of $2.25, representing about 230.5% upside from its current price of $0.68.

Amount of Analyst Coverage

Envoy Medical has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Envoy Medical are expected to grow in the coming year, from ($0.29) to ($0.19) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Envoy Medical is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Envoy Medical is -0.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.23% of the float of Envoy Medical has been sold short.

Short Interest Ratio / Days to Cover

Envoy Medical has a short interest ratio ("days to cover") of 2.25, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Envoy Medical has recently decreased by 10.56%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Envoy Medical does not currently pay a dividend.

Dividend Growth

Envoy Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

5 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Envoy Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

7.10% of the stock of Envoy Medical is held by insiders.

Percentage Held by Institutions

8.59% of the stock of Envoy Medical is held by institutions.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 8/06/2026
• Next Earnings (Estimated): 8/06/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:COCH
• CIK: 1840877
• Web: www.envoymedical.com
• Phone: 877-900-3277
• Fax: N/A
• Employees: 34
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Envoy Medical: $2.25
• High Price Target: $2.50
• Low Price Target: $2.00
• Potential Upside/Downside: +230.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$23.76 million
• Net Margins: -9,875.64%
• Pretax Margin: -9,875.64%
• Return on Equity: N/A
• Return on Assets: -177.92%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.27
• Quick Ratio: 2.14

Sales & Book Value

• Annual Sales: $240 thousand
• Price / Sales: 218.08
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.42) per share
• Price / Book: -1.62

Miscellaneous

• Outstanding Shares: 76,880,000
• Free Float: 71,422,000
• Market Cap: $52.34 million
• Optionable: Not Optionable
• Beta: 1.90